Premium
Cognitive behaviour therapy and medication in the treatment of obsessive–compulsive disorder
Author(s) -
O'Connor K. P.,
Aardema F.,
Robillard S.,
Guay S.,
Pélissier M.C.,
Todorov C.,
Borgeat F.,
Leblanc V.,
Grenier S.,
Doucet P.
Publication year - 2006
Publication title -
acta psychiatrica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.849
H-Index - 146
eISSN - 1600-0447
pISSN - 0001-690X
DOI - 10.1111/j.1600-0447.2006.00767.x
Subject(s) - obsessive compulsive , cognition , cognitive therapy , cognitive behaviour therapy , psychotherapist , psychology , psychiatry , behaviour therapy , clinical psychology , medicine
Objective: To compare cognitive behaviour therapy (CBT) with CBT plus medication; medication alone; and placebo in the treatment of adult obsessive–compulsive disorder (OCD). Method: Forty‐eight participants (43 completers) were recruited into two protocols. In the first protocol, 21 people with OCD were randomly allocated to either a standard medication (fluvoxamine) or standard placebo condition for a 5‐month period. Both these groups subsequently received CBT for a further 5 months. In the second protocol, 22 people with OCD received CBT, one group was already stabilized on an antidepressant of choice; the second group was drug naïve. Results: All active treatments, but not the placebo, showed clinical improvement. There was no difference in treatment response to CBT regardless of whether participants had previously received medication or placebo. Conclusion: CBT has a more specific antiobsessional effect than medication but CBT plus medication shows greatest overall clinical improvement in mood.